Marknadens oro över hur Trumps handelstullar skulle komma att påverka verksamheten kom på skam.
Q1 sales +11% y-o-y coupled with improving margins We cut '25e-'26e adj.
Sales in line with ABGSCe, ARR slightly below Limited, downward consensus estimate revisions Highlig...
Sales +11% y-o-y, in line with ABGSCe 5% adj. EBIT beat, 9% adj.
Redeye is encouraged to see solid financial performance in Q1, showing good growth, improving gross ...
Redeye provides an initial comment on the Q1 2025 report from Tradedoubler.
Redeye thinks that Momentum Group reported mixed results with both sales and EBITA slightly below ou...
The 12-month safety results confirm and extend the earlier results after 3 months, adding support bo...
CEO Rikard Fröberg gives a short introduction of his background and his plans for Hexatronic.
Redeye updates its view of Curasight following the Q1 report and recent events in the company, inclu...
8%/9% adj. EBITDA vs ABGSCe/cons in Q1 Cons estimates likely up low to mid single digits on adj.
Redeye comments on SHH´s Q1 2025. SSH posted a growth of 8% Y/Y slightly lower than our estimate.
Taaleri’s continuing earnings of EUR 9.3m declined 9% y/y and were 6% below our estimate.
Net sales SEK 596m, +1% vs ABGSCe, +1% vs Factset cons.
Redeye updates in EG7 ahead of Q1-results (due May 15) where we expect stable performance from EG7’s...
